<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05093881</url>
  </required_header>
  <id_info>
    <org_study_id>PMC-P-07-01</org_study_id>
    <nct_id>NCT05093881</nct_id>
  </id_info>
  <brief_title>Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study</brief_title>
  <official_title>Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pharmicell Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pharmicell Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Long-term follow-up is designed to evaluate the safety of patient with Alcoholic Liver&#xD;
      Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the safety for 60 months after a single dose of Cellgram-LC in patients with&#xD;
      alcoholic liver cirrhosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 24, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2028</completion_date>
  <primary_completion_date type="Anticipated">August 24, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of AESI</measure>
    <time_frame>For 5 years</time_frame>
    <description>death, neoplasms or malignancies in tissues or organs, Immune response including exacerbation or new outbreaks of previous autoimmune diseases, Other delayed AE related to Cellgram LC)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of Liver transplant</measure>
    <time_frame>For 5 years</time_frame>
    <description>Liver transplant</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Alcoholic Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Cellgram-LC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Cellgram-LC</intervention_name>
    <description>Patients who had administered Cellgram-LC in PMC-P-07 study</description>
    <arm_group_label>Cellgram-LC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Those who participated in PMC-P-07 clinical trials and received Cellgram-LC&#xD;
&#xD;
          2. Those who voluntarily agreed in writing to participate in this investigation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Moonyoung Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wonju Severance Christian Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>JIYEOUN JEONG</last_name>
    <phone>82-2-3496-0134</phone>
    <email>jyjeong@pharmicell.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Soonchunhyang University Hospital</name>
      <address>
        <city>Bucheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang-gyun Kim</last_name>
      <email>mcnulty@schmc.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University Hospital</name>
      <address>
        <city>Cheonan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>hongsoo kim</last_name>
      <email>khskhs@sch.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gangwon National University Hospital</name>
      <address>
        <city>ChunCheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daehee Choi</last_name>
      <email>dhchoi-md@kangwon.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hallym Univ. Medical Center</name>
      <address>
        <city>ChunCheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ki-tae Seok</last_name>
      <email>diarrhea100@hanmail.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gangneung Asan Hospital</name>
      <address>
        <city>Gangneung-si</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gapjin Cheon</last_name>
      <email>1000@gnah.co.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eunpyeong St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sihyeon Bae</last_name>
      <email>baesh@catholic.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yeonseok Seo</last_name>
      <email>drseo@korea.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeonghwan Yoon</last_name>
      <email>yoonjh@snu.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaeyoung Jang</last_name>
      <email>jyjang@schmc.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wonju Severance Christian Hospital</name>
      <address>
        <city>Wonju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moonyoung Kim</last_name>
      <email>drkimmy@yonsei.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Sun-gu Baek</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yongin Severance Hospital</name>
      <address>
        <city>Yongin</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jakyung Kim</last_name>
      <email>ceciliak@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 13, 2021</study_first_submitted>
  <study_first_submitted_qc>October 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Liver Cirrhosis, Alcoholic</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

